This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hallstrom, A. P. Search for Related Content PubMed PubMed Citation Articles by Hallstrom, A. P.

Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit

Alfred P. Hallstrom, PhD^*, John H. McAnulty, MD, FACC, Bruce L. Wilkoff, MD, FACC, Dean Follmann, PhD^#, Merritt H. Raitt, MD, FACC, Mark D. Carlson, MD, FACC, Anne M. Gillis, MD^¶, Hue-Teh Shih, MD, FACC^||, Judy L. Powell, RN^*, Hank Duff, MD^¶, Blair D. Halperin, MD, FACC the Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators

^* University of Washington, Seattle, Washington, USA
Oregon Health Sciences University/Collaborating Medical Centers, Portland, Oregon, USA
University Hospitals of Cleveland, Cleveland, Ohio, USA
Cleveland Clinic Foundation, Cleveland, Ohio, USA
^|| University of Texas Medical School, Houston, Texas, USA
^¶ University of Calgary/Calgary Regional Health Authority Hospitals, Calgary, Alberta, Canada
^# National Heart, Lung and Blood Institute, Bethesda, Maryland, USA

View larger version (13K): [in a new window]   Figure 1 Survival free of ventricular tachyarrhythmia for the first and for the second through sixth sextiles. ICD = implantable cardioverter defibrillator.

View larger version (16K): [in a new window]   Figure 2 Survival (from death) by treatment arm for the first sextile (A) and for the second through sixth sextiles (B). AAD = antiarrhythmic drug; ICD = implantable cardioverter defibrillator.